Microbiome Dysbiosis and Predominant Bacterial Species as Human Cancer Biomarkers

Purpose To evaluate bacterial agents as cancer biomarkers. Methods and Results Various bacterial species have been demonstrated to involve in human cancers. However, the data is not enough for better understanding of predominant specific species. Application of a rapid and early-diagnostic, cost-effective, non-invasive, and inclusive method is a crucial approach for obtaining valid results. The role of Helicobacter pylori ( H. pylori ) in gastric and duodenal cancer has been confirmed. From investigation among previous publications, we attempted to make it clear which bacterial species significantly and specifically increase in various cancer types. It was unraveled that there is significant change in Granulicatella adiacens ( G. adiacens ) in lung cancer (LC), Fusobacterium nucleatum ( F. nucleatum ) in colorectal cancer (CRC), H. pylori and Porphyromonas gingivalis ( P. gingivalis ) in pancreatic cancer, and Streptococcus spp. in oral cancer. Conclusion Alteration in the cell cycle by means of different mechanisms such as inflammation, alteration in cell signaling, invasion and immune evasion, specific niche colonization, induction of DNA damage and mutation, expression of some microRNAs, and enhancing epigenetic effects are the most common mechanisms employed by bacterial species.